Chi Shao Extract.

Red peony and salvia are routinely combined where circulation is the target, and both carry compounds that reduce platelet aggregation. The activity is additive rather than complementary.

Paeoniflorin and paeonol reduce platelet aggregation, and nattokinase acts on fibrin from the other direction. Stacking them puts additive pressure on normal clotting.

Ginkgolide B blocks platelet activating factor while peony compounds reduce aggregation by a separate route. The two effects add together.

Long-chain omega-3 fats shift eicosanoid balance toward less platelet aggregation, on top of the antiplatelet compounds in red peony. The combined effect on normal clotting is larger than either alone.

Salicin metabolites reduce platelet thromboxane formation, a different step from the peony compounds. Combining them adds two independent brakes on aggregation.

Red peony root is tannin-rich, and gallotannins form insoluble complexes with ferric and ferrous iron before it reaches the mucosal transporter. This is the same chemistry behind tea reducing iron absorption from a meal, and it applies to a tannin-bearing root extract. Separating a tannin-rich extract from an iron dose by a couple of hours is the ordinary handling.

Any non-heme iron source is subject to complexation by galloyl-bearing polyphenols in the same meal or dose. The effect is dose-dependent on the polyphenol load, not on the iron form alone. Timing the two apart preserves both.

Garlic organosulfur compounds and peony root constituents are each described as reducing platelet aggregation in laboratory work. Stacking two such botanicals may raise the combined effect on aggregation, and none of it has been measured as a combination. Anyone on antiplatelet or anticoagulant medicine, or facing surgery, should raise the pairing with their clinician before adding it.

Aged garlic preparations carry water-soluble organosulfur compounds with reported antiplatelet activity in vitro. Combining them with a peony extract described the same way may make the combined platelet effect larger than either alone. The mechanism is described in class terms; the size of any combined effect in people is not established.

Gingerols are reported to inhibit thromboxane-driven platelet aggregation in laboratory systems. Paired with a peony root extract described as influencing platelet function, the effects on aggregation may add. This is a flag to disclose alongside any medicine affecting clotting, not a claimed benefit.

Curcuminoids influence platelet aggregation and arachidonic acid signalling in laboratory work, the same axis attributed to peony root constituents. Together the effect on aggregation may be larger than either alone. Both also appear in the same traditional and modern joint-comfort formulas, so the pairing is common and worth flagging rather than hiding.

Bromelain has documented fibrinolytic and platelet-modulating activity in vitro. Combining it with a peony extract described as affecting blood flow properties may compound the effect on clotting. The combination is not something to add without discussing it with a prescriber if any anticoagulant is in play.

At high intakes tocopherol reduces platelet adhesion and can interfere with vitamin K-dependent clotting factor activity. Layered onto a botanical described as affecting platelet function, the two point the same way. Ordinary dietary amounts of vitamin E are a different matter from concentrated supplemental doses.

Resveratrol inhibits platelet aggregation in vitro at concentrations well above what typical oral doses reach in blood. That makes the practical size of an additive effect with peony root uncertain. It is listed for completeness because the direction of the mechanism is consistent, not because the interaction is established in people.

Peony root and licorice root are combined in long-standing classical formulas, and the pairing is one of the most frequently used couplets in that tradition. Licorice root brings its own consideration, since glycyrrhizin affects potassium and blood pressure handling with prolonged use. The basis here is documented traditional practice, not a controlled combination trial.

The peony and licorice pairing appears across classical formulas and modern proprietary blends. Glycyrrhizin in licorice increases potassium loss and can raise blood pressure with sustained use, so the pairing carries a monitoring point that has nothing to do with the peony. Deglycyrrhizinated licorice does not carry glycyrrhizin and also drops the constituent the traditional pairing was built around.

Red peony root and dang gui appear together in classical formulas concerned with circulation. Dang gui contains coumarin-type constituents, so the pairing stacks two botanicals with reported effects on clotting. Traditional co-use is the basis; the combined effect on coagulation in people has not been quantified here.

Ascorbate reduces ferric iron and keeps it soluble, which partly offsets the iron-binding effect of a tannin-rich extract taken in the same meal. It does not remove the interaction, and it does not make co-dosing equivalent to separating the doses. This matters most for anyone relying on non-heme iron intake.

Polyphenol and tannin fractions can oxidise the thiazole ring of thiamine in laboratory conditions, lowering measurable thiamine. Whether this happens meaningfully during normal gut transit at supplement doses is not established. It is included as a mechanistic flag at low confidence rather than an interaction to act on.